NINLARO (Millennium Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the NINLARO drug offered from Millennium Pharmaceuticals, Inc.. This Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Millennium Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | ixazomib |
| SUBSTANCE NAME: | IXAZOMIB CITRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-11-20 |
| END MARKETING DATE: | 0000-00-00 |
NINLARO HUMAN PRESCRIPTION DRUG Details:
| Item Description | NINLARO from Millennium Pharmaceuticals, Inc. |
| LABELER NAME: | Millennium Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.3(mg/1) |
| START MARKETING DATE: | 2015-11-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63020-078_da385b56-052e-4df2-89c4-643916068070 |
| PRODUCT NDC: | 63020-078 |
| APPLICATION NUMBER: | NDA208462 |
Other IXAZOMIB CITRATE Pharmaceutical Manufacturers / Labelers:
